Clinical Trials Browser

Phase 2 × icotinib × Gastrointestinal × Clear all

NCT01855854 2019-07-05

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms